CRESCENT CREATES MEDICAL INDUSTRY SPECIFIC VPN

CCES TO LAUNCH BLUEGATE(tm)IN THE TEXAS MEDICAL CENTER

August 20, 2002 (Houston) Crescent Communications Inc. (OTCBB:CCES) announced the creation of an Industry Specific Virtual Private Network (ISVPN). The first ISVPN, BLUEGATE, a division of Crescent, is a unique end-to-end telecommunications infrastructure targeted for the medical industry. Also in development are service sets targeted for the banking and financial community and the legal profession. Crescent will provide a secure channel of Internet communication for these market segments free from risk of interception or unauthorized transmission.

BLUEGATE will be launched in Houston, home of the Texas Medical Center, the largest medical complex in the world. Future plans include expansion to Dallas, Austin and San Antonio. Crescent intends to expand BLUEGATEs services to every major medical market in the United States.

About Crescent Communications, Inc.

Crescent Communications, Inc. (OTCBB: CCES) is a value added network provider, (VAN), focused on the small business and enterprise-level market segments providing industry specific end-to-end solutions for vertical markets such as medical, high end graphics and printing, legal and financial. Crescent provides wireless, DSL and traditional communication technologies using several regional and national carriers. Besides managed VPNs, Crescent delivers application and web hosting services as well as managed firewall services from its ATM core fiber backbone network.

This news release contains forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

For additional information:

Company contact:
Manfred Sternberg, CEO
701 North Post Oak Rd, Suite 630
Houston, Texas 77024
(713) 682-7400
(713) 682-7402 fax
www.crescentb.com
email: investorrelations@crescentb.com